Jiangsu Yuexing Pharmaceutical

Jiangsu Yuexing Pharmaceutical is a specialized pharmaceutical company based in the China Medical City of Taizhou, Jiangsu Province. Established in 2001, the firm focuses on the development, manufacturing, and commercialization of high-quality generic medications and active pharmaceutical ingredients (APIs). Its core therapeutic areas include cardiovascular health, metabolic diseases, and infectious diseases, with a product portfolio featuring widely used treatments for hypertension and diabetes. The company operates advanced, GMP-compliant production lines for various oral solid dosage forms, including sustained-release tablets. Jiangsu Yuexing is actively involved in China's generic drug consistency evaluation process to ensure its products meet international standards. It serves as a significant player in the regional life sciences ecosystem, contributing to both domestic supply and export markets.